Cargando…
Antiphospholipid (Hughes) Syndrome: An Overview
In conclusion, the following observations can be made. aPL are present in approximately 2% to 4% of the normal population and the prevalence increases with age. There is a high prevalence among patients with autoimmune connective tissue disorders, especially SLE. There is an association with both ve...
Autor principal: | D’Cruz, David P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7123322/ http://dx.doi.org/10.1007/1-84628-009-5_2 |
Ejemplares similares
-
Antiphospholipid (Hughes) syndrome: beyond pregnancy morbidity and thrombosis
por: Mialdea, Maria, et al.
Publicado: (2009) -
Hughes Syndrome: The Antiphospholipid Syndrome
por: Hughes, Graham R V
Publicado: (1998) -
An update on the management of antiphospholipid syndrome
por: Rodziewicz, Mia, et al.
Publicado: (2020) -
Prolactin May Not Play a Role in Primary Antiphospholipid (Hughes') Syndrome
por: Neves Junior, Manoel Tavares, et al.
Publicado: (2011) -
Controversies in the antiphospholipid syndrome: can we ever stop warfarin?
por: Fonseca, Ana G, et al.
Publicado: (2008)